Travelers Companies stock kpis
Want to see TRV full AI Analyst Report?
Net Written Premiums by Segment
Travelers Companies reported net written premiums by segment of $11.48B in Q3 2026, down 0.4% from Q2 2026 and up 0.1% year over year. The highest value was $11.53B in Q2 2026.
Shows premium growth or decline after reinsurance across business lines (like commercial vs. personal insurance), highlighting which segments are expanding, where risk exposure sits, and how reinsurance buying affects the company’s retained revenue.
Business Insurance is clearly the growth engine—sustained, accelerating new‑business wins are lifting scale and underpinning underwriting leverage, even as management intentionally trims national property where pricing/terms aren’t attractive. Bond & Specialty’s jump (surety-driven) is meaningful but lumpy, so treat that growth as volatile upside rather than steady revenue. Personal Insurance shows recurring seasonality with strong mid‑year renewal flows; recent reinsurance tweaks (personal CAT XOL not renewed) and Q2 catastrophe hits increase short‑term volatility. Overall, premium momentum supports the company’s strong ROE and capital returns, but CAT and PYD reversal remain key risks.
TRV Net Written Premiums by Segment
| Period | Business Insurance | Bond & Speciality Insurance | Personal Insurance | Total |
|---|---|---|---|---|
| Q3 2026Sep 30, 2026 | $5.87B | $1.21B | $4.40B | $11.48B |
| Q2 2026Jun 30, 2026 | $5.98B | $1.24B | $4.31B | $11.53B |
| Q1 2026Mar 31, 2026 | $5.77B | $1.07B | $3.49B | $10.32B |
| Q4 2025Dec 31, 2025 | $5.51B | $1.10B | $4.24B | $10.86B |
| Q3 2025Sep 30, 2025 | $5.67B | $1.08B | $4.72B | $11.47B |
| Q2 2025Jun 30, 2025 | $5.76B | $1.08B | $4.67B | $11.52B |
| Q1 2025Mar 31, 2025 | $5.70B | $999.00M | $3.82B | $10.52B |
| Q4 2024Dec 31, 2024 | $5.43B | $1.05B | $4.26B | $10.74B |
| Q3 2024Sep 30, 2024 | $5.52B | $1.07B | $4.73B | $11.32B |
| Q2 2024Jun 30, 2024 | $5.54B | $1.04B | $4.54B | $11.12B |
| Q1 2024Mar 31, 2024 | $5.60B | $943.00M | $3.64B | $10.18B |
| Q4 2023Dec 31, 2023 | $5.02B | $989.00M | $3.99B | $9.99B |
| Q3 2023Sep 30, 2023 | $5.08B | $1.00B | $4.41B | $10.49B |
| Q2 2023Jun 30, 2023 | $5.17B | $964.00M | $4.18B | $10.32B |
| Q1 2023Mar 31, 2023 | $5.16B | $886.00M | $3.35B | $9.40B |
| Q4 2022Dec 31, 2022 | $4.39B | $924.00M | $3.52B | $8.83B |
| Q3 2022Sep 30, 2022 | $4.37B | $964.00M | $3.86B | $9.20B |
| Q2 2022Jun 30, 2022 | $4.37B | $962.00M | $3.69B | $9.02B |
| Q1 2022Mar 31, 2022 | $4.50B | $882.00M | $2.98B | $8.37B |
| Q4 2021Dec 31, 2021 | $3.97B | $905.00M | $3.12B | $8.00B |
| Q3 2021Sep 30, 2021 | $4.02B | $894.00M | $3.41B | $8.32B |
| Q2 2021Jun 30, 2021 | $3.98B | $854.00M | $3.30B | $8.13B |
| Q1 2021Mar 31, 2021 | $4.13B | $723.00M | $2.66B | $7.50B |

